Moderna Inc Corporate Analyst Meeting Transcript
Good morning and welcome to Moderna's Annual R&D Day. (Operator Instructions) Please be advised that this call is being recorded. At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.
Thank you, Catherine. Good morning, everyone. Thank you for joining Moderna's R&D Day. Today, we will present new data and updates of many of our pipeline candidates. You will hear from Moderna's management and clinical team leads as well as from key opinion leaders. You can access the press release issued this morning as well as the slides that we'll be reviewing by going to the Investors section of our website. Presenting today from Moderna are Stéphane Bancel, our Chief Executive Officer; Tal Zaks, our Chief Medical Officer; Stephen Hoge, our President; Juan Andres, Chief Technical Operations and Quality Officer; Jacqueline Miller, Senior Vice President, Infectious Diseases; Lori Panther, Senior Director, Clinical Development, Infectious Diseases; and Allison
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |